Cerebrospinal Fluid P-Tau(181P): Biomarker for Improved Differential Dementia Diagnosis

The goal of this study is to investigate the value of tau phosphorylated at threonine 181 (P-tau(181P)) in the Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarker panel for differential dementia diagnosis in autopsy confirmed AD and non-AD patients. The study population consisted of 140 aut...

Descripción completa

Detalles Bibliográficos
Autores principales: Struyfs, Hanne, Niemantsverdriet, Ellis, Goossens, Joery, Fransen, Erik, Martin, Jean-Jacques, De Deyn, Peter P., Engelborghs, Sebastiaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470274/
https://www.ncbi.nlm.nih.gov/pubmed/26136723
http://dx.doi.org/10.3389/fneur.2015.00138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470274/
https://www.ncbi.nlm.nih.gov/pubmed/26136723
http://dx.doi.org/10.3389/fneur.2015.00138

Ejemplares similares